![[object Object],[object Object],[object Object],[object Object],[object Object],MeTA Baseline Pharmaceutical Situation Assessments](https://image.slidesharecdn.com/baselineassessmentsjordanforumsamia230910-129976998149-phpapp01/85/meta-baseline-assessments-1-320.jpg)
![[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],OUTLINE](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (20)
Destacado
Similar a MeTA Baseline Assessments
Similar a MeTA Baseline Assessments (20)
MeTA Baseline Assessments
- 4. OBJECTIVE track national progress Long term evaluation of outcomes Level of engagement of different stakeholders country-specific indicators
- 9. METHODOLOGY Data Collection Background Scan ( National + International Sources) Key Informants for National Data Collate, synthesize and validate data and sources Review Data with Key Informants and Council Discussion & Formulation of Recommendations Validation of Data Collection by Harvard Team
- 17. Jordan Abeer Rabaya - MeTA Secretariat Pharmacist Email: metajordan@yahoo.com Rania Bader - Country Consultant Email: raniasb2002@yahoo.com Salah Gammouh- WHO Technical Officer for MeTA (Level II surveys) Email: [email_address] International Samia Saad - International Consultant (Baseline Coordinator) Email: samiasaad@gmail.com Wilbert Bannenberg - Technical Director, Int. MeTA Sec. Email: wbannenberg@metasecretariat.org Key Contacts MeTA Baseline Assessments
- 18. Thank You for your attention!
Notas del editor
- Enable country-specific indicators to be identified by the national MeTA multi-stakeholder groups Track own national progress and demonstrate level of engagement of different stakeholders to MeTA process Provide foundation for longer term evaluation of outcomes and impact beyond pilot phase